Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, USA.
Tissue Eng Part A. 2021 Nov;27(21-22):1376-1386. doi: 10.1089/ten.TEA.2020.0330. Epub 2021 Mar 30.
A key challenge in the treatment of large bone defects is the need to provide an adequate and stable vascular supply as new tissue develops. Bone tissue engineering applies selected biomaterials and cell types to create an environment that promotes tissue formation, maturation, and remodeling. Mesenchymal stromal cells (MSCs) have been widely used in these strategies because of their established effects on bone formation, and their ability to act as stabilizing pericytes that support vascular regeneration by endothelial cells (ECs). However, the creation of vascularized bone tissue requires coupling of osteogenesis and vasculogenesis in a three-dimensional (3D) biomaterial environment. In the present study, 3D fibrin hydrogels containing MSCs and ECs were prevascularized for 7 days to create an endothelial network in the matrix, and were subsequently cultured for a further 14 days under either continued vasculogenic stimulus, a combination of vasculogenic and osteogenic (hybrid) stimulus, or only osteogenic stimulus. It was found that ECs produced robust vessel networks in 3D fibrin matrices over 7 days of culture, and these networks continued to expand over the 14-day treatment period under vasculogenic conditions. Culture in hybrid medium resulted in maintenance of vessel networks for 14 days, while osteogenic culture abrogated vessel formation. These trends were mirrored in data representing overall cell viability and cell number in the 3D fibrin constructs. MSCs were found to colocalize with EC networks under vasculogenic and hybrid conditions, suggesting pericyte-like function. The bone marker alkaline phosphatase increased over time in hybrid and osteogenic media, but mineral deposition was evident only under purely osteogenic conditions. These results suggest that hybrid media compositions can support some aspects of multiphase tissue formation, but that alternative strategies are needed to obtain robust, concomitant vascularization, and osteogenesis in engineered tissues . Impact statement The combined use of mesenchymal stromal cells (MSCs) and endothelial cells to concomitantly produce mature bone and a nourishing vasculature is a promising tissue engineering approach to treating large bone defects. However, it is challenging to create and maintain vascular networks in the presence of osteogenic cues. This study used a 3D fibrin matrix to demonstrate that prevascularization of the construct can lead to maintenance of vessel structures over time, but that osteogenesis is compromised under these conditions. This work illuminates the capacity of MSCs to serve as both supportive pericytes and as osteoprogenitor cells, and motivates new strategies for coupling osteogenesis and vasculogenesis in engineered bone tissues.
在治疗大骨缺损时,一个关键挑战是需要提供足够且稳定的血管供应,以促进新组织的形成。骨组织工程应用选定的生物材料和细胞类型,创造一个促进组织形成、成熟和重塑的环境。间充质基质细胞(MSCs)因其对骨形成的既定作用以及作为支持内皮细胞(ECs)血管再生的稳定周细胞的能力,已被广泛应用于这些策略中。然而,在三维(3D)生物材料环境中,实现血管化骨组织需要成骨和血管生成的偶联。在本研究中,将含有 MSCs 和 ECs 的 3D 纤维蛋白水凝胶预血管化 7 天,在基质中形成内皮网络,随后在持续血管生成刺激、血管生成和成骨(混合)刺激的组合或仅成骨刺激下再培养 14 天。结果发现,ECs 在 3D 纤维蛋白基质中培养 7 天时产生了强大的血管网络,并且在血管生成条件下,这些网络在 14 天的治疗期间继续扩展。在混合培养基中培养导致血管网络维持 14 天,而成骨培养则消除了血管形成。这些趋势与代表 3D 纤维蛋白结构中整体细胞活力和细胞数量的数据一致。在血管生成和混合条件下,MSCs 被发现与 EC 网络共定位,提示具有周细胞样功能。碱性磷酸酶等成骨标志物随时间推移在混合和成骨培养基中增加,但仅在纯成骨条件下才可见矿物质沉积。这些结果表明,混合培养基成分可以支持多相组织形成的某些方面,但需要替代策略来获得工程化组织中强大、同时的血管生成和成骨。